In a phase III RCT of 1800 healthy Chinese children aged 2-5, three lots of a tetanus toxoid-conjugated PCV13 met lot-to-lot equivalence for all 13 serotypes; seropositivity was at least 99% for 12 serotypes and 85.6-88.3% for serotype 3.
RCTn = 1,800
Shi et al. Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2-5 years: A phase III study